Many patients who expected to be prescribed insulin are now prescribed GLP-1 drugs instead, further blurring the line between the two categories in the public consciousness
10.1016/j.freeradbiomed.2019.04.008 72 Villas-BasJ
What to Expect During IV Therapy for Fertility Consultation: A thorough review of health history, fertility challenges, and blood tests to identify nutrient gaps
"My insurance company spent more money denying my Zepbound appeal than they would have spent just covering the medication," observes Michael S., whose denial was eventually overturned after external review
Body composition, visceral fat, and hormone balance are equally important
Risk Factors Requiring Elevated Screening Personal history of any eating disorder, including sub-threshold presentations, adolescent dieting pathology, or ARFID Family history of restrictive eating, excessive exercise, or diet-culture-driven food restriction High dietary restraint, rigid food rules, or BMI-focused identity Any prior mental health diagnosis doubles two-year eating disorder risk post-initiation Adolescent and young adult patients developmentally most vulnerable Off-label use in patients without metabolic comorbidities the cosmetic use population most likely to include subclinical disordered eating What the Physiology Actually Produces in a Restrictive Mind For a patient with anorexia nervosa in whom the ego-syntonic experience of not being hungry is already rewarding GLP-1-mediated appetite suppression does not feel like a side effect to manage